Published in Surgery Litigation and Law Weekly, March 30th, 2007
First Quarter Highlights
* Revenue $219.4 million, 7% above first quarter 2006, 4% above in constant currency. CooperVision (CVI) revenue $183.6 million, up 1% in constant currency; CooperSurgical (CSI) revenue $35.8 million, up 19% with 10% organic growth.
* Reported EPS 12 cents. These earnings include share-based compensation expenses of 12 cents, acquisition and restructuring expenses, intellectual property and securities litigation costs, write-off of net deferred financing costs and acquired in-process research and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly